Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release
Authors:
- Jeong-Sook ParkJeong-Sook Park
- Chong-Kook KimCKChong-Kook Kim
- 1 January 2010
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 383 (1-2) , 209-215
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Development and evaluation of novel itraconazole-loaded intravenous nanoparticlesInternational Journal of Pharmaceutics, 2008
- Advances in lipid nanodispersions for parenteral drug delivery and targetingAdvanced Drug Delivery Reviews, 2008
- Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug☆Advanced Drug Delivery Reviews, 2007
- A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorptionJournal of Controlled Release, 2006
- Intravenous itraconazole emulsions produced by SolEmuls technologyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal CandidiasisAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics and Safety of a 7-Day Administration of Intravenous Itraconazole followed by a 14-Day Administration of Itraconazole Oral Solution in Patients with Hematologic MalignancyAntimicrobial Agents and Chemotherapy, 2001
- Pharmacology of ItraconazoleDrugs, 2001
- Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInternational Journal of Pharmaceutics, 2000
- Enhanced solubility and dissolution rate of itraconazole by a solid dispersion techniqueInternational Journal of Pharmaceutics, 1999